RELEAF PHARMA LTD

Active London

Dispensing chemist in specialised stores

Dispensing chemist in specialised stores
R

RELEAF PHARMA LTD

Dispensing chemist in specialised stores

Founded 15 Jan 2025 Active London, England website.com
Dispensing chemist in specialised stores

Previous Company Names

3PD LTD 15 Jan 2025 — 1 Dec 2025
Accounts Submitted 14 Jan 2026 Next due 15 Oct 2026 5 months remaining
Confirmation Submitted 26 Feb 2026 Next due 12 Mar 2027 10 months remaining
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

1 Kings Avenue London N21 3NA England

Full company profile for RELEAF PHARMA LTD (16185677), an active company based in London, England. Incorporated 15 Jan 2025. Dispensing chemist in specialised stores. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Awaiting first accounts
For period ending 31 May 2026
Due by 15 October 2026 5 months remaining

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
Bradley Steve TysonDirectorBritishEngland3015 Jan 2025Active
Cox, MichelleDirectorBritishEngland4017 Oct 2025Active
Tyson, Bradley StevenDirectorBritishUnited Kingdom3026 Feb 2026Active

Shareholders

Shareholders (3)

Refine Group Holdings Limited
50.0%
50
Releaf Dispensary Limited
50.0%
50

Persons with Significant Control

Persons with Significant Control (3)

3 Active

Bradley Steven Tyson

British

Active
Notified 15 Jan 2025
Residence England
DOB October 1995
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Refine Bs Holdings Limited

Unknown

Active
Notified 22 Jan 2026
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Releaf Dispensary Limited

Unknown

Active
Notified 16 Sept 2025
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent
  • Right To Appoint And Remove Directors

Group Structure

Group Structure

RELEAF PHARMA LTD Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
26 Feb 2026Persons With Significant ControlChange to Refine Bs Holdings Limited as a person with significant control on 26 Feb 2026
26 Feb 2026Confirmation StatementConfirmation statement made on 26 Feb 2026 with updates
26 Feb 2026OfficersAppointment of Mr Bradley Steven Tyson as director on 26 Feb 2026
22 Jan 2026Persons With Significant ControlCessation of Bradley Steven Tyson as a person with significant control on 22 Jan 2026
22 Jan 2026Persons With Significant ControlRefine Bs Holdings Limited notified as a person with significant control
26 Feb 2026 Persons With Significant Control

Change to Refine Bs Holdings Limited as a person with significant control on 26 Feb 2026

26 Feb 2026 Confirmation Statement

Confirmation statement made on 26 Feb 2026 with updates

26 Feb 2026 Officers

Appointment of Mr Bradley Steven Tyson as director on 26 Feb 2026

22 Jan 2026 Persons With Significant Control

Cessation of Bradley Steven Tyson as a person with significant control on 22 Jan 2026

22 Jan 2026 Persons With Significant Control

Refine Bs Holdings Limited notified as a person with significant control

Recent Activity

Latest Activity

Change to Refine Bs Holdings Limited as a person with significant control on 26 Feb 2026

2 months ago on 26 Feb 2026

Confirmation statement made on 26 Feb 2026 with updates

2 months ago on 26 Feb 2026

Appointment of Mr Bradley Steven Tyson as director on 26 Feb 2026

2 months ago on 26 Feb 2026

Cessation of Bradley Steven Tyson as a person with significant control on 22 Jan 2026

3 months ago on 22 Jan 2026

Refine Bs Holdings Limited notified as a person with significant control

3 months ago on 22 Jan 2026